DK1404872T3 - Fremgangsmåde til selektion af en DNA-sekvens med transkriptionsmodulerende aktivitet med en vektor indeholdende et element med en gentranskriptionsundertrykkende aktivitet - Google Patents

Fremgangsmåde til selektion af en DNA-sekvens med transkriptionsmodulerende aktivitet med en vektor indeholdende et element med en gentranskriptionsundertrykkende aktivitet

Info

Publication number
DK1404872T3
DK1404872T3 DK02741531T DK02741531T DK1404872T3 DK 1404872 T3 DK1404872 T3 DK 1404872T3 DK 02741531 T DK02741531 T DK 02741531T DK 02741531 T DK02741531 T DK 02741531T DK 1404872 T3 DK1404872 T3 DK 1404872T3
Authority
DK
Denmark
Prior art keywords
transcriptional
activity
selecting
dna sequence
vector containing
Prior art date
Application number
DK02741531T
Other languages
Danish (da)
English (en)
Inventor
Arie Pieter Otte
Arthur Leo Kruckeberg
Original Assignee
Chromagenics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01202581A external-priority patent/EP1273666A1/en
Application filed by Chromagenics Bv filed Critical Chromagenics Bv
Application granted granted Critical
Publication of DK1404872T3 publication Critical patent/DK1404872T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK02741531T 2001-07-04 2002-06-14 Fremgangsmåde til selektion af en DNA-sekvens med transkriptionsmodulerende aktivitet med en vektor indeholdende et element med en gentranskriptionsundertrykkende aktivitet DK1404872T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP01202581A EP1273666A1 (en) 2001-07-04 2001-07-04 Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
US30319901P 2001-07-05 2001-07-05
PCT/NL2002/000390 WO2003004704A2 (en) 2001-07-04 2002-06-14 Method of selecting dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
US10/190,312 US7192741B2 (en) 2001-07-04 2002-07-05 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences

Publications (1)

Publication Number Publication Date
DK1404872T3 true DK1404872T3 (da) 2007-02-19

Family

ID=47915807

Family Applications (8)

Application Number Title Priority Date Filing Date
DK06124470.3T DK1806407T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK06124491.9T DK1842919T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med antirepressoraktivitet
DK06124482.8T DK1829972T3 (da) 2001-07-04 2002-06-14 DNA-Sekvenser med anti-repressoraktivitet
DK05076209T DK1600510T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med antirepressoraktivitet
DK06124465.3T DK1808488T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK02741531T DK1404872T3 (da) 2001-07-04 2002-06-14 Fremgangsmåde til selektion af en DNA-sekvens med transkriptionsmodulerende aktivitet med en vektor indeholdende et element med en gentranskriptionsundertrykkende aktivitet
DK06124475.2T DK1829971T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK06124481.0T DK1845162T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet

Family Applications Before (5)

Application Number Title Priority Date Filing Date
DK06124470.3T DK1806407T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK06124491.9T DK1842919T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med antirepressoraktivitet
DK06124482.8T DK1829972T3 (da) 2001-07-04 2002-06-14 DNA-Sekvenser med anti-repressoraktivitet
DK05076209T DK1600510T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med antirepressoraktivitet
DK06124465.3T DK1808488T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK06124475.2T DK1829971T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK06124481.0T DK1845162T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet

Country Status (22)

Country Link
US (9) US7192741B2 (pt)
EP (8) EP1829972B1 (pt)
JP (3) JP4500044B2 (pt)
KR (2) KR100942117B1 (pt)
CN (1) CN1266282C (pt)
AT (8) ATE467682T1 (pt)
AU (3) AU2002314629B2 (pt)
BR (1) BRPI0210771B8 (pt)
CA (2) CA2812799C (pt)
CY (1) CY1107678T1 (pt)
DE (8) DE60219221T2 (pt)
DK (8) DK1806407T3 (pt)
ES (8) ES2344071T3 (pt)
HK (1) HK1068652A1 (pt)
IL (4) IL159674A0 (pt)
MX (1) MXPA03011801A (pt)
NO (1) NO338477B1 (pt)
NZ (1) NZ530218A (pt)
PT (1) PT1600510E (pt)
SG (1) SG143066A1 (pt)
WO (1) WO2003004704A2 (pt)
ZA (1) ZA200309599B (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1806407T3 (da) 2001-07-04 2010-08-16 Chromagenics Bv DNA-sekvenser med anti-repressoraktivitet
CA2722998C (en) * 2002-06-14 2014-12-02 Chromagenics B.V. A method for simultaneous production of multiple proteins; vectors and cells for use therein
EP1513936A2 (en) * 2002-06-14 2005-03-16 Chromagenics B.V. Use of repression blocking sequences in methods for enhancing gene expression
PT1523496E (pt) 2002-07-18 2011-09-29 Merus B V Produção de misturas de anticorpos de forma recombinante
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
ES2373549T3 (es) 2002-12-18 2012-02-06 Chromagenics B.V. Método para mejorar la producción de proteínas.
DE60312039T2 (de) 2002-12-20 2007-11-08 Chromagenics B.V. Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
WO2004106375A1 (en) 2003-05-30 2004-12-09 Merus Biopharmaceuticals B.V. I.O. Fab library for the preparation of anti vegf and anti rabies virus fabs
AU2004278517B2 (en) 2003-10-02 2010-04-01 Crucell Holland B.V. Packaging cells for recombinant adenovirus
WO2005059149A2 (en) * 2003-12-12 2005-06-30 Chromagenics B.V. Improved protein production
CA2554054C (en) 2004-01-20 2013-06-04 Merus B.V. Mixtures of binding proteins
US7825232B2 (en) * 2004-07-08 2010-11-02 Chromagenics B.V. Sequence for improving expression of nucleic acid
WO2006018319A1 (en) * 2004-08-18 2006-02-23 Bayer Cropscience Gmbh Plants with increased plastidic activity of r3 starch-phosphorylating enzyme
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
BRPI0517380A (pt) * 2004-11-08 2008-10-07 Chromagenics Bv molécula de dna, cassete de expressão, célula hospedeira, e, métodos para gerar uma célula hospedeira que expressa um polipeptìdeo de interesse e para produzir um polipeptìdeo de interesse
US8999667B2 (en) 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
SI1809750T1 (sl) * 2004-11-08 2012-08-31 Chromagenics Bv Izbira gostiteljskih celic, ki imajo visok nivo izraĹľanja proteina
WO2006054561A1 (ja) * 2004-11-18 2006-05-26 National University Of Corporation Hiroshima University 遺伝子増幅により形成された反復配列から、発現抑制されているタンパク質を発現させる方法、キット、および形質転換体
US7968700B2 (en) 2006-03-20 2011-06-28 Chromagenics B.V. Expression augmenting DNA fragments, use thereof, and methods for finding thereof
US20080124760A1 (en) 2006-07-26 2008-05-29 Barbara Enenkel Regulatory Nucleic Acid Elements
EP2109674A2 (en) * 2007-01-08 2009-10-21 Millipore Corporation High expression cell line that eliminates gene amplification
US9284563B2 (en) 2009-06-15 2016-03-15 Cellagenics B.V. Stringent selectable markers
US8566596B2 (en) 2010-08-24 2013-10-22 Cisco Technology, Inc. Pre-association mechanism to provide detailed description of wireless services
DK2611915T3 (da) 2010-09-01 2015-06-22 Cellagenics B V Nukleinsyrefragmenter fra en ribosomal proteinpromoter til forstærkning af genekspression
SI2838918T1 (sl) 2012-04-20 2019-11-29 Merus Nv Postopki in sredstva za proizvodnjo heterodimernih IG-podobnih molekul
EP2869845B1 (en) 2012-07-06 2019-08-28 Genmab B.V. Dimeric protein with triple mutations
SG10201705787VA (en) 2012-09-27 2017-08-30 Merus Nv BISPECIFIC IgG ANTIBODIES AS T CELL ENGAGERS
US10417380B1 (en) 2013-12-31 2019-09-17 Mckesson Corporation Systems and methods for determining and communicating a prescription benefit coverage denial to a prescriber
US10489552B2 (en) 2014-02-14 2019-11-26 Mckesson Corporation Systems and methods for determining and communicating patient incentive information to a prescriber
CA2941030A1 (en) 2014-02-28 2015-09-03 Merus N.V. Antibodies that bind egfr and erbb3
MX2016011155A (es) 2014-02-28 2017-02-22 Merus Nv Anticuerpo que une erbb-2 y erbb-3.
US10157262B1 (en) 2015-03-10 2018-12-18 Mckesson Corporation Systems and methods for determining patient financial responsibility for multiple prescription products
SI3115376T1 (sl) 2015-07-10 2018-12-31 Merus N.V. Humana protitelesa, ki vežejo CD3
CN108602888B (zh) 2015-10-23 2022-10-04 美勒斯公司 抑制癌症生长的结合分子
US11514137B1 (en) 2016-03-30 2022-11-29 Mckesson Corporation Alternative therapy identification system
US10999224B1 (en) 2017-02-01 2021-05-04 Mckesson Corporation Method and apparatus for parsing an electronic message and constructing multiple differently prioritized messages therefrom
MX2019011660A (es) 2017-03-31 2019-11-18 Merus Nv Anticuerpos biespecificos que se unen al receptor 2 del factor de crecimiento humano (erbb-2) y receptor 3 del factor de crecimiento humano (erbb3) para usarse en el tratamiento de celulas que tienen un gen de fusion de neuregulina-1 (nrg1).
MA49846A (fr) 2017-08-09 2020-06-17 Merus Nv Anticorps qui se lient à l'egfr et à cmet
US10862832B1 (en) 2018-07-24 2020-12-08 Mckesson Corporation Computing system and method for automatically reversing an action indicated by an electronic message
US11043437B2 (en) 2019-01-07 2021-06-22 Applied Materials, Inc. Transparent substrate with light blocking edge exclusion zone
US11562437B1 (en) 2019-06-26 2023-01-24 Mckesson Corporation Method, apparatus, and computer program product for providing estimated prescription costs
US11636548B1 (en) 2019-06-26 2023-04-25 Mckesson Corporation Method, apparatus, and computer program product for providing estimated prescription costs
EP3772518A1 (en) 2019-08-07 2021-02-10 Merus N.V. Modified human variable domains
WO2021155369A1 (en) * 2020-01-31 2021-08-05 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods to identify genetic silencers and applications thereof
US11610240B1 (en) 2020-02-17 2023-03-21 Mckesson Corporation Method, apparatus, and computer program product for partitioning prescription transaction costs in an electronic prescription transaction
IL298394A (en) 2020-05-21 2023-01-01 Merus Nv Methods and means for producing ig-like molecules
US11587657B2 (en) 2020-09-04 2023-02-21 Mckesson Corporation Method, apparatus, and computer program product for performing an alternative evaluation procedure in response to an electronic message
CN113539357B (zh) * 2021-06-10 2024-04-30 阿里巴巴达摩院(杭州)科技有限公司 基因检测方法、模型训练方法、装置、设备及系统

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US719271A (en) * 1902-01-13 1903-01-27 Solomon P Smith Furnace.
US5610053A (en) 1993-04-07 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells
US5972605A (en) * 1994-07-07 1999-10-26 Geron Corporation Assays for regulators of mammalian telomerase expression
WO1996030522A1 (fr) * 1995-03-24 1996-10-03 Shionogi & Co., Ltd. Molecule d'adn relative a la suppression d'une expression genique et nouvelle proteine
DE19539493A1 (de) * 1995-10-24 1997-04-30 Thomae Gmbh Dr K Starker homologer Promotor aus Hamster
US5773695A (en) 1996-01-26 1998-06-30 North Carolina State University Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells
US6037525A (en) * 1996-08-01 2000-03-14 North Carolina State University Method for reducing expression variability of transgenes in plant cells
US5888809A (en) 1997-05-01 1999-03-30 Icos Corporation Hamster EF-1α transcriptional regulatory DNA
KR100795626B1 (ko) 1998-07-21 2008-01-17 코브라 바이오매뉴팩쳐링 피엘씨. 도처에 있는 염색질 개방 요소(유씨오이)를 포함하는폴리뉴클레오티드
JP4450995B2 (ja) 1998-08-14 2010-04-14 クロマヘニクス ベスローテン フェンノートシャップ Ｄｎａ配列を検出する方法、ｄｎａ配列、ｄｎａ構築物を作製する方法およびそれらの使用
US6800457B2 (en) 1998-09-22 2004-10-05 Bristol-Myers Squibb Company Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
US6521419B1 (en) 1998-09-22 2003-02-18 Kanakaraju Koduri Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
AU1128400A (en) 1998-10-22 2000-05-08 Medical College Of Georgia Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
NZ517215A (en) * 1999-08-25 2004-01-30 Immunex Corp Compositions and methods for improved cell culture
US6586205B1 (en) 2000-02-11 2003-07-01 Millennium Pharmaceuticals, Inc. 43239 a novel GPCR-like molecule and uses thereof
US20030166042A1 (en) 2000-02-11 2003-09-04 Millennium Pharmaceuticals, Inc. Novel seven-transmembrane proteins/G-protein coupled receptors
CN1461343B (zh) 2000-09-20 2012-10-31 Emd密理博公司 多核苷酸
EP1273666A1 (en) 2001-07-04 2003-01-08 Chromagenics B.V. Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
DK1806407T3 (da) 2001-07-04 2010-08-16 Chromagenics Bv DNA-sekvenser med anti-repressoraktivitet
EP1513936A2 (en) 2002-06-14 2005-03-16 Chromagenics B.V. Use of repression blocking sequences in methods for enhancing gene expression
CA2722998C (en) * 2002-06-14 2014-12-02 Chromagenics B.V. A method for simultaneous production of multiple proteins; vectors and cells for use therein
ES2373549T3 (es) 2002-12-18 2012-02-06 Chromagenics B.V. Método para mejorar la producción de proteínas.
DE60312039T2 (de) 2002-12-20 2007-11-08 Chromagenics B.V. Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können

Also Published As

Publication number Publication date
US20070026498A1 (en) 2007-02-01
DE60215502D1 (de) 2006-11-30
JP4500044B2 (ja) 2010-07-14
KR100942117B1 (ko) 2010-02-12
AU2002314629B2 (en) 2007-08-30
DK1842919T3 (da) 2010-08-16
KR20090037485A (ko) 2009-04-15
ES2344072T3 (es) 2010-08-17
MXPA03011801A (es) 2005-03-07
ES2344073T3 (es) 2010-08-17
EP1404872B1 (en) 2006-10-18
WO2003004704A3 (en) 2003-10-16
AU2007234619B2 (en) 2011-06-02
US20070031933A1 (en) 2007-02-08
EP1404872A2 (en) 2004-04-07
IL159674A (en) 2009-02-11
BR0210771A (pt) 2004-07-13
AU2007234619A1 (en) 2007-12-13
ATE467682T1 (de) 2010-05-15
DE60236379D1 (de) 2010-06-24
US20070031936A1 (en) 2007-02-08
DE60237048D1 (de) 2010-08-26
CA2812799C (en) 2016-01-26
JP5014443B2 (ja) 2012-08-29
ATE474053T1 (de) 2010-07-15
DK1829972T3 (da) 2010-09-13
EP1842919A1 (en) 2007-10-10
JP2010131024A (ja) 2010-06-17
US7662591B2 (en) 2010-02-16
US20070026499A1 (en) 2007-02-01
DE60215502T2 (de) 2007-08-30
ZA200309599B (en) 2006-05-31
DE60219221D1 (de) 2007-05-10
CA2812799A1 (en) 2003-01-16
EP1845162B1 (en) 2010-05-05
JP2010131025A (ja) 2010-06-17
EP1829971A3 (en) 2008-06-04
DE60236334D1 (de) 2010-06-17
US7749733B2 (en) 2010-07-06
ES2348174T3 (es) 2010-11-30
NZ530218A (en) 2005-09-30
CN1266282C (zh) 2006-07-26
EP1808488B1 (en) 2010-07-14
EP1600510A3 (en) 2006-02-22
BRPI0210771B1 (pt) 2015-12-22
ATE358183T1 (de) 2007-04-15
SG143066A1 (en) 2008-06-27
CN1524128A (zh) 2004-08-25
DK1806407T3 (da) 2010-08-16
IL159674A0 (en) 2004-06-20
IL193373A (en) 2010-12-30
JP2004533262A (ja) 2004-11-04
EP1806407A3 (en) 2008-06-04
US20030199468A1 (en) 2003-10-23
DK1808488T3 (da) 2010-10-18
EP1600510A2 (en) 2005-11-30
EP1829971B1 (en) 2010-05-05
CA2450020C (en) 2013-08-13
ATE343004T1 (de) 2006-11-15
ATE466942T1 (de) 2010-05-15
DE60236331D1 (de) 2010-06-17
ES2344071T3 (es) 2010-08-17
DK1829971T3 (da) 2010-08-16
ES2285630T3 (es) 2007-11-16
BRPI0210771B8 (pt) 2021-05-25
EP1829972A3 (en) 2007-10-24
ATE466941T1 (de) 2010-05-15
EP1808488A2 (en) 2007-07-18
HK1068652A1 (en) 2005-04-29
US20070128717A1 (en) 2007-06-07
PT1600510E (pt) 2007-06-25
ES2274045T3 (es) 2007-05-16
EP1808488A3 (en) 2007-11-14
US7192741B2 (en) 2007-03-20
EP1842919B1 (en) 2010-05-05
DE60236332D1 (de) 2010-06-17
WO2003004704A2 (en) 2003-01-16
US7736868B2 (en) 2010-06-15
EP1845162A1 (en) 2007-10-17
EP1829972B1 (en) 2010-05-12
CA2450020A1 (en) 2003-01-16
AU2011202193B2 (en) 2011-09-29
EP1600510B1 (en) 2007-03-28
CY1107678T1 (el) 2013-04-18
DE60219221T2 (de) 2008-01-03
ES2344070T3 (es) 2010-08-17
NO20040011L (no) 2004-03-03
IL193374A (en) 2010-12-30
KR100942116B1 (ko) 2010-02-12
EP1806407A2 (en) 2007-07-11
DK1600510T3 (da) 2007-06-25
EP1829972A2 (en) 2007-09-05
US7736869B2 (en) 2010-06-15
AU2011202193A1 (en) 2011-06-02
ATE466944T1 (de) 2010-05-15
US7655441B2 (en) 2010-02-02
JP5014444B2 (ja) 2012-08-29
EP1829971A1 (en) 2007-09-05
EP1806407B1 (en) 2010-05-05
ATE466943T1 (de) 2010-05-15
NO338477B1 (no) 2016-08-22
DE60236333D1 (de) 2010-06-17
US20070031934A1 (en) 2007-02-08
KR20090037960A (ko) 2009-04-16
US20070031935A1 (en) 2007-02-08
US7659094B2 (en) 2010-02-09
DK1845162T3 (da) 2010-08-16
ES2344074T3 (es) 2010-08-17
US7951586B2 (en) 2011-05-31
US7736870B2 (en) 2010-06-15
US20070037256A1 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
DK1404872T3 (da) Fremgangsmåde til selektion af en DNA-sekvens med transkriptionsmodulerende aktivitet med en vektor indeholdende et element med en gentranskriptionsundertrykkende aktivitet
ATE397092T1 (de) Methode zur direkten sequenzierung von nukleinsäuren
ATE338828T1 (de) Amplifikation von einfachen sequenz wiederholungen
DE69133533D1 (de) Expression von Phytase in Pflanzen
DE60036645D1 (de) Methoden zur identifizierung evolutionär signifikanter änderungen in polynukleotid- und polypeptidsequenzen in domestizierten pflanzen und tieren
ATE435914T1 (de) Induktion der blütenbildung
ATA3442001A (de) Vorrichtung zur durchführung von extraktionen bzw. chemischen reaktionen bei erhöhter temperatur und erhöhtem druck
TH124110B (th) ลำดับนิวคลีโอไทด์ที่กำหนดรหัสโปรตีนฆ่าแมลง
TH97397A (th) จีนของ Bacillus Thuringiensis ชนิดใหม่ที่มีแอคทิวิตีเลพิดอพทีแรน
ITGE20040063A1 (it) Metodo per incrementare l'efficacia biologica dei campi elettromagnetici usati per il trattamento di esseri umani animali o piante.
DE60303257D1 (de) Substanzen, Sequenzen und Methoden zur Identifizierung epidemischer Methicillin-resistenter Staphylococcus aureus Stämme
DE50203158D1 (de) Dna-expressionskonstrukt zur behandlung von infektionen mit leishmaniose